{"doc_id": "PMID-10380915.txt", "sent_id": "S1", "tokens": ["Tyrphostin", "AG-490", "inhibits", "cytokine", "-", "mediated", "JAK3", "/", "STAT5a", "/", "b", "signal", "transduction", "and", "cellular", "proliferation", "of", "antigen", "-", "activated", "human", "T", "cells", "."], "sentence": "Tyrphostin AG-490 inhibits cytokine - mediated JAK3 / STAT5a / b signal transduction and cellular proliferation of antigen - activated human T cells .", "event_mentions": [], "entity_mentions": [{"id": "T1", "text": "JAK3", "entity_type": "Protein", "start": 6, "end": 6}, {"id": "T2", "text": "STAT5a", "entity_type": "Protein", "start": 8, "end": 8}, {"id": "T3", "text": "b", "entity_type": "Protein", "start": 10, "end": 10}]}
{"doc_id": "PMID-10380915.txt", "sent_id": "S2", "tokens": ["Janus", "kinase", "3", "(", "JAK3", ")", "is", "a", "cytoplasmic", "tyrosine", "kinase", "required", "for", "T", "cell", "development", "and", "activated", "by", "cytokines", "that", "utilize", "the", "interleukin-2", "(IL-2)", "receptor", "common", "gamma", "chain", "(", "gamma(c)", ")", "."], "sentence": "Janus kinase 3 ( JAK3 ) is a cytoplasmic tyrosine kinase required for T cell development and activated by cytokines that utilize the interleukin-2 (IL-2) receptor common gamma chain ( gamma(c) ) .", "event_mentions": [], "entity_mentions": [{"id": "T4", "text": "Janus kinase 3", "entity_type": "Protein", "start": 0, "end": 2}, {"id": "T5", "text": "JAK3", "entity_type": "Protein", "start": 4, "end": 4}, {"id": "T6", "text": "interleukin-2 (IL-2) receptor common gamma chain", "entity_type": "Protein", "start": 23, "end": 28}, {"id": "T7", "text": "gamma(c)", "entity_type": "Protein", "start": 30, "end": 30}]}
{"doc_id": "PMID-10380915.txt", "sent_id": "S3", "tokens": ["Genetic", "inactivation", "of", "JAK3", "is", "manifested", "as", "severe", "combined", "immunodeficiency", "disease", "(", "SCID", ")", "in", "humans", "and", "mice", "."], "sentence": "Genetic inactivation of JAK3 is manifested as severe combined immunodeficiency disease ( SCID ) in humans and mice .", "event_mentions": [], "entity_mentions": [{"id": "T8", "text": "JAK3", "entity_type": "Protein", "start": 3, "end": 3}]}
{"doc_id": "PMID-10380915.txt", "sent_id": "S4", "tokens": ["These", "findings", "have", "suggested", "that", "JAK3", "represents", "a", "pharmacological", "target", "to", "control", "certain", "lymphoid", "-", "derived", "diseases", "."], "sentence": "These findings have suggested that JAK3 represents a pharmacological target to control certain lymphoid - derived diseases .", "event_mentions": [], "entity_mentions": [{"id": "T9", "text": "JAK3", "entity_type": "Protein", "start": 5, "end": 5}]}
{"doc_id": "PMID-10380915.txt", "sent_id": "S5", "tokens": ["Here", "we", "provide", "novel", "evidence", "that", "AG-490", "potently", "inhibits", "the", "autokinase", "activity", "of", "JAK3", "and", "tyrosine", "phosphorylation", "and", "DNA", "binding", "of", "signal", "transducer", "and", "activator", "of", "transcription", "5a", "and", "5b", "(", "STAT5a", "/", "b", ")", "."], "sentence": "Here we provide novel evidence that AG-490 potently inhibits the autokinase activity of JAK3 and tyrosine phosphorylation and DNA binding of signal transducer and activator of transcription 5a and 5b ( STAT5a / b ) .", "event_mentions": [], "entity_mentions": [{"id": "T10", "text": "JAK3", "entity_type": "Protein", "start": 13, "end": 13}, {"id": "T11", "text": "signal transducer and activator of transcription 5a", "entity_type": "Protein", "start": 21, "end": 27}, {"id": "T12", "text": "5b", "entity_type": "Protein", "start": 29, "end": 29}, {"id": "T13", "text": "STAT5a", "entity_type": "Protein", "start": 31, "end": 31}, {"id": "T14", "text": "b", "entity_type": "Protein", "start": 33, "end": 33}]}
{"doc_id": "PMID-10380915.txt", "sent_id": "S6", "tokens": ["Similar", "inhibitory", "effects", "were", "observed", "with", "other", "cytokines", "that", "use", "gamma(c)", "."], "sentence": "Similar inhibitory effects were observed with other cytokines that use gamma(c) .", "event_mentions": [], "entity_mentions": [{"id": "T15", "text": "gamma(c)", "entity_type": "Protein", "start": 10, "end": 10}]}
{"doc_id": "PMID-10380915.txt", "sent_id": "S7", "tokens": ["AG-490", "also", "inhibited", "IL-2", "-", "mediated", "proliferative", "growth", "in", "human", "T", "cells", "with", "an", "IC50", ")", "=", "25", "microM", "that", "was", "partially", "recoverable", "."], "sentence": "AG-490 also inhibited IL-2 - mediated proliferative growth in human T cells with an IC50 ) = 25 microM that was partially recoverable .", "event_mentions": [], "entity_mentions": [{"id": "T16", "text": "IL-2", "entity_type": "Protein", "start": 3, "end": 3}]}
{"doc_id": "PMID-10380915.txt", "sent_id": "S8", "tokens": ["Moreover", ",", "we", "demonstrate", "that", "this", "inhibitor", "prevented", "tetanus", "toxoid", "antigen", "-", "specific", "T", "cell", "proliferation", "and", "expansion", "but", "failed", "to", "block", "activation", "of", "Zap70", "or", "p56Lck", "after", "anti-CD3", "stimulation", "of", "human", "T", "cells", "."], "sentence": "Moreover , we demonstrate that this inhibitor prevented tetanus toxoid antigen - specific T cell proliferation and expansion but failed to block activation of Zap70 or p56Lck after anti-CD3 stimulation of human T cells .", "event_mentions": [], "entity_mentions": [{"id": "T17", "text": "Zap70", "entity_type": "Protein", "start": 24, "end": 24}, {"id": "T18", "text": "p56Lck", "entity_type": "Protein", "start": 26, "end": 26}]}
{"doc_id": "PMID-10380915.txt", "sent_id": "S9", "tokens": ["Taken", "together", ",", "these", "findings", "suggest", "that", "AG-490", "inhibits", "the", "JAK3", "-", "mediated", "Type", "II", "signaling", "pathway", "but", "not", "the", "T", "cell", "receptor", "-", "derived", "Type", "I", "pathway", "and", "possesses", "therapeutic", "potential", "for", "T", "cell", "-", "derived", "pathologies", "such", "as", "graft-versus-host", "disease", ",", "allergy", ",", "and", "autoimmune", "disorders", "."], "sentence": "Taken together , these findings suggest that AG-490 inhibits the JAK3 - mediated Type II signaling pathway but not the T cell receptor - derived Type I pathway and possesses therapeutic potential for T cell - derived pathologies such as graft-versus-host disease , allergy , and autoimmune disorders .", "event_mentions": [], "entity_mentions": [{"id": "T19", "text": "JAK3", "entity_type": "Protein", "start": 10, "end": 10}]}
